1. Feds ‘very concerned’ about serious side effect in AstraZeneca’s Covid vaccine trial  Raw Story
  2. Nobody wants vaccine trials to fail. But they just might.  The Washington Post
  3. U.S. FDA's Hahn plans 'significant' work with AstraZeneca in COVID-19 trial inquiry  Reuters
  4. NIH Worried About Side Effect in Coronavirus Vaccine Trial  Medscape
  5. View Full Coverage on Google News

The U.S. Food and Drug Administration said on Tuesday AstraZeneca Plc's COVID-19 vaccine trial in the United States is still on hold, and it was working with the company to figure out if there was a significant safety issue or not.The U.S. Food and Drug Administration said on Tuesday AstraZeneca Plc's COVID-19 vaccine trial in the United States is still on hold, and it was working with the company to figure out if there was a significant safety issue or not.

U.S. FDA investigating AstraZeneca's COVID-19 vaccine candidate | Reuters

There is progress toward a COVID-19 vaccine.There is progress toward a COVID-19 vaccine.

US regulators have not allowed AstraZeneca's vaccine trial to resume in America and first want to determine if the jab or another factor caused a UK participant to suffer spinal cord inflammation.US regulators have not allowed AstraZeneca's vaccine trial to resume in America and first want to determine if the jab or another factor caused a UK participant to suffer spinal cord inflammation.

US regulators are 'very concerned' about the side effects of AstraZeneca's vaccine | Daily Mail Online

The Government needs to react to where we are instead of selling us the vaccine silver bulletThe Government needs to react to where we are instead of selling us the vaccine silver bullet

Political dreams won’t fix this nightmare

Mary Kate Rylands discusses the power dynamics surrounding the search for a Covid-19 vaccine.

Power, populism and cooperation: the politicisation of vaccines | Palatinate Online

Page UnavailablePage Unavailable

Page Unavailable - ABC News

Over 300 volunteers have been inoculated during the post-registration trials of Russia's COVID-19 vaccine, dubbed Sputnik V, around 14 percent of them have reported fatigue, muscle pain or high body temperature, Russian Health Minister Mikhail Murashko said on Tuesday. "Over 300 persons have been vaccinated.

Over 300 Volunteers Get Russian COVID-19 Vaccine - Novinite.com - Sofia News Agency

Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday. The investigator, Alberto Borobia, said there were enough reserve volunteersSome volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday. The investigator, Alberto Borobia, said there were enough reserve volunteers

Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare, investigator says

Recon: AstraZeneca resumes COVID vaccine trials in South Africa, Brazil, US study still on hold | RAPS

A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.

Fifteen scientists launch critique of Russia’s COVID-19 vaccine data – EURACTIV.com

“We don’t have all facts, so we don’t know the causation per se of this, but we really need to look into it," FDA Commissioner Stephen Hahn said.“We don’t have all facts, so we don’t know the causation per se of this, but we really need to look into it," FDA Commissioner Stephen Hahn said.

Two German biotechs, BioNTech and CureVac, have been at the cutting edge of the hunt for a COVID-19 vaccine—a time consuming and costly process. In order to get both over the finish line, the German government is making a big down payment in both candidates' development.Two German biotechs, BioNTech and CureVac, have been at the cutting edge of the hunt for a COVID-19 vaccine—a time consuming and costly process. In order to get both over the finish line, the German government is making a big down payment in both candidates' development.

BioNTech, CureVac bag $745M in German funding for COVID-19 vaccine hopefuls | FiercePharma

The Korea Herald is South Korea’s largest English-language daily and the country’s sole member of the Asia News Network (ANN). The Korea Herald is South Korea’s largest English-language daily and the country’s sole member of the Asia News Network (ANN).

The Korea Herald

egypttoday,Politics,Business,Economy,Art,culture,Local news,Special interest,Press Review,News,ResourcesHead of the Russian Direct Investment Fund Kirill Dmitriev said Tuesday that Egypt is one of Russia’s main partners in the region.

Egypt to be gate for "Sputnik V" vaccine to Africa: Russian official - Egypt Today

China's COVID-19 vaccine could be ready for public in November: expert - CGTN

Fox News medical contributor Dr. Marc Siegel said Monday that the common flu, unlike coronavirus, is a "moving target" that often changes form from year to year, while COVID is more static in that regard.Fox News medical contributor Dr. Marc Siegel said Monday that the common flu, unlike coronavirus, is a "moving target" that often changes form from year to year, while COVID is more static in that regard.

Bloomberg - Are you a robot?

Chung said the government will negotiate with the relevant international organizations and vaccine makers to secure the early supply of the COVID-19 vaccines and would buy more as the development proceeds.Chung said the government will negotiate with the relevant international organizations and vaccine makers to secure the early supply of the COVID-19 vaccines and would buy more as the development proceeds.

S.Korea to secure coronavirus vaccines for 60 percent of population: PM Chung - World - The Jakarta Post

The number of confirmed cases of the coronavirus that causes COVID-19 edged closer to 30 million on Tuesday, as a Chinese health official said a vaccine may...The number of confirmed cases of the coronavirus that causes COVID-19 edged closer to 30 million on Tuesday, as a Chinese health official said a vaccine may...

Coronavirus update: Global cases edge toward 30 million, and China says vaccine may be ready by November - MarketWatch

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science, Technology, Health & Fitness news & opinions from leading columnists.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Health officials say returning to a normal way of life will require a vaccine. But it is still not a simple task as researchers are still trying to understand the virus.Health officials say returning to a normal way of life will require a vaccine. But it is still not a simple task as researchers are still trying to understand the virus.

A vaccine for COVID-19 is said to be close, but questions, challenges remain | WHNT.com

Decision taken following a surge in infections over the weekend when the Gulf state registered 1,000 cases a day.Decision taken following a surge in infections over the weekend when the Gulf state registered 1,000 cases a day.

UAE announces emergency approval for use of coronavirus vaccine | Coronavirus pandemic News | Al Jazeera

This comes on the heels of a resumption in the company's U.K. trial for AZD1222.This comes on the heels of a resumption in the company's U.K. trial for AZD1222.

AstraZeneca Resumes COVID-19 Vaccine Candidate Trial in South Africa | The Motley Fool

“Many have called to ask us some more detail about the risk of the vaccine, whether what happened with that vaccine had anything to do with the one we are studying."“Many have called to ask us some more detail about the risk of the vaccine, whether what happened with that vaccine had anything to do with the one we are studying."

Volunteers quit coronavirus trial in Spain amid concerns - New York Daily News

The experimental vaccine is drawing scrutiny after a participant in clinical trials was diagnosed with transverse myelitis, an inflammatory syndrome.

AstraZeneca COVID-19 vaccine trial suspended in US for at least several more days amid concerns over serious complication

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.

Researchers trial inhaled versions of Oxford and Imperial Covid-19 vaccine candidates - world news - Hindustan Times

Pfizer has said that Phase III trial participants were experiencing mild-to-moderate side effects with its investigational Covid-19 vaccine candidate.Pfizer has said that Phase III trial participants were experiencing mild-to-moderate side effects with its investigational Covid-19 vaccine candidate.

Pfizer says Covid-19 vaccine showed moderate side effects

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.

Biopharma Update on the Novel Coronavirus: September 14 | BioSpace

Experts call the global response to the COVID-19 pandemic a "collective failure."Experts call the global response to the COVID-19 pandemic a "collective failure."

Pandemic total passes 29 million as cases hit daily high | CIDRAP

The magazine’s Ethicist columnist on whether participating in a vaccine trial means you can act as if you’re part of an “immune elite” — and more.The magazine’s Ethicist columnist on whether participating in a vaccine trial means you can act as if you’re part of an “immune elite” — and more.

President Donald Trump reiterated his belief that a coronavirus vaccine may arrive before Election Day, even as top administration health officials have rebuffed such a timeline.President Donald Trump reiterated his belief that a coronavirus vaccine may arrive before Election Day, even as top administration health officials have rebuffed such a timeline.

Coronavirus update: Trump says vaccine ready within weeks; Pfizer says some patients show side effects

Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said.Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said.

China Covid-19 vaccine may be ready for public in November, say officials

About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.

14% of volunteers testing pioneering Russian Covid-19 vaccine ‘Sputnik V’ have experienced side effects, health ministry says — RT Russia & Former Soviet Union

The United Arab Emirates (UAE) on Monday granted emergency approval for use of a coronavirus vaccine developed in China, six weeks after human trials on the vaccine started in the country.

UAE approves urgent use of China-developed COVID-19 vaccine after test on 31,000 volunteers - Global Times

Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, surmised that if we are able to bring a safe and effective vaccine to market by the end of 2020, it will still likely be late into 2021 before we are able to do once normal things, like going to a theater and comfortably not wearing a mask. Here’s everything else you need to know this week.Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, surmised that if we are able to bring a safe and effective vaccine to market by the end of 2020, it will still likely be late into 2021 before we are able to do once normal things, like going to a theater and comfortably not wearing a mask. Here’s everything else you need to know this week.

AstraZeneca resumed its COVID-19 vaccine trials after uncovering a mysterious reaction | Popular Science

Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.

There Won’t Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers

Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.

There Won't Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers

404 Not Found

Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators are continuing to investigate.Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators are continuing to investigate.

Feds ‘Very Concerned’ About AstraZeneca COVID-19 Vaccine Side Effect

Emergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures - ZAWYA MENA EditionEmergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures

The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.

In Global Covid-19 Vaccine Race, Chinese Shot Receives First Foreign Approval - WSJ

UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been releasedUK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been released

Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency - Scientific American

COVID-19 vaccines being developed in China might be available for use by the general public as early as November, according to a top scientist with the Chinese Center...COVID-19 vaccines being developed in China might be available for use by the general public as early as November, according to a top scientist with the Chinese Center...

COVID-19 Vaccine Likely Available for Public Use in November, Top Chinese Scientist Says - Sputnik International